Bicycle Therapeutics Income Statement (2018-2025) | BCYC

Income Statement Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 1.66M1.61M1.06M6.38M1.52M0.61M5.28M1.13M1.57M3.84M3.85M1.81M1.78M4.33M0.80M3.86M8.40M3.04M8.40M4.90M11.40M5.35M-16.34M10.40M9.36M2.68M-30.37M9.98M2.92M11.73M
Operating items
Research & Development 3.71M5.64M6.49M6.28M6.54M6.08M6.65M7.77M7.96M7.36M10.06M9.69M11.72M10.51M12.96M14.28M19.85M22.75M24.72M32.21M39.72M39.87M44.70M34.86M40.06M48.27M49.78M59.06M71.03M58.43M
Wages, Salaries and Other 5.72M5.53M5.84M6.42M7.05M7.06M7.30M
Selling, General & Administrative 1.99M2.33M2.11M3.40M2.97M4.79M3.40M5.00M6.20M7.15M10.85M8.14M7.34M8.11M8.84M16.96M11.82M10.05M10.68M14.49M14.79M16.28M14.87M16.38M15.95M18.26M21.59M21.12M18.49M18.86M
Restructuring Costs 2.02M1.92M2.53M2.58M2.19M2.33M2.47M
Other Operating Expenses 0.92M-0.00M-2.02M-1.92M-2.53M-2.58M-2.19M-2.33M-2.47M
Operating Expenses 6.62M7.97M8.60M9.68M9.51M10.87M10.04M12.77M14.15M14.52M20.91M17.83M19.06M18.63M21.80M31.24M31.68M32.80M35.40M46.70M54.51M56.15M59.57M51.25M56.01M66.52M71.37M80.18M89.52M77.28M
Operating Income -2.89M-6.36M-7.54M-3.29M-7.99M-10.25M-4.76M-11.64M-12.58M-10.68M-17.06M-16.02M-17.28M-14.29M-18.02M-27.38M-27.30M-29.76M-32.21M-41.80M-43.11M-50.80M-54.23M-31.72M-46.65M-63.85M-67.66M-70.20M-86.60M-65.55M
EBIT -2.89M-6.36M-7.54M-3.29M-7.99M-10.25M-4.76M-11.64M-12.58M-10.68M-17.06M-16.02M-17.28M-14.29M-18.02M-27.38M-27.30M-29.76M-32.21M-41.80M-43.11M-50.80M-54.23M-31.72M-46.65M-63.85M-67.66M-70.20M-86.60M-65.55M
Non-operating items
Interest & Investment Income -0.00M0.03M0.09M0.06M0.09M0.44M0.22M0.21M0.37M0.07M0.03M0.01M0.02M0.02M0.06M0.22M0.91M1.99M2.64M2.93M0.81M3.98M6.28M5.62M7.77M10.58M10.30M8.41M7.47M6.70M
Other Non Operating Income -0.04M-1.36M0.81M-3.19M-2.18M0.07M0.10M-1.00M-0.20M0.74M0.16M
Non Operating Income -0.02M-1.33M0.90M-3.13M-2.09M0.44M0.22M0.21M0.37M0.07M-0.43M-0.51M-0.80M-0.80M-0.76M-0.60M0.03M1.17M1.81M2.12M-0.01M3.17M5.46M4.80M6.95M9.60M14.73M8.36M7.42M6.66M
Net income details
EBT -4.98M-7.69M-6.64M-6.42M-10.08M-9.81M-4.54M-11.43M-12.21M-10.60M-17.49M-16.53M-18.07M-15.09M-19.85M-27.98M-27.27M-28.59M-32.43M-39.68M-43.12M-47.63M-52.55M-26.91M-39.70M-54.25M-58.75M-61.84M-79.18M-58.90M
Tax Provisions -0.00M0.08M0.14M-0.33M-0.14M-0.11M-0.10M-0.50M-0.06M-0.34M-0.20M-0.41M-0.79M-0.42M-0.45M-0.24M4.56M-0.62M-0.52M2.30M-2.99M-0.40M0.12M-3.45M-1.10M-1.10M-0.23M0.20M
Profit After Tax -4.98M-7.69M-6.64M-6.50M-10.22M-9.48M-4.41M-11.32M-12.12M-10.14M-17.43M-16.20M-17.91M-14.70M-18.02M-27.60M-26.83M-28.35M-29.98M-39.10M-42.60M-49.90M-49.10M-26.56M-39.81M-50.80M-51.83M-60.80M-79.00M-59.10M
Income from Continuing Operations -4.98M-7.69M-6.64M-6.50M-10.22M-9.48M-4.41M-11.32M-12.11M-10.10M-17.43M-16.19M-17.87M-14.68M-19.06M-27.56M-26.83M-28.35M-36.99M-39.06M-42.60M-49.93M-49.57M-26.51M-39.81M-50.80M-57.65M-60.74M-78.95M-59.10M
Consolidated Net Income -4.98M-7.69M-6.64M-6.50M-10.22M-9.48M-4.41M-11.32M-12.11M-10.10M-17.43M-16.19M-17.87M-14.68M-19.06M-27.56M-26.83M-28.35M-36.99M-39.06M-42.60M-49.93M-49.57M-26.51M-39.81M-50.80M-57.65M-60.74M-78.95M-59.10M
Income towards Parent Company -4.98M-7.69M-6.64M-6.50M-10.22M-9.48M-4.41M-11.32M-12.11M-10.10M-17.43M-16.19M-17.87M-14.68M-19.06M-27.56M-26.83M-28.35M-36.99M-39.06M-42.60M-49.93M-49.57M-26.51M-39.81M-50.80M-57.65M-60.74M-78.95M-59.10M
Net Income towards Common Stockholders -2.53M-7.69M-6.64M-6.50M-10.22M-9.48M-4.41M-11.32M-12.12M-10.14M-17.43M-16.19M-17.91M-14.68M-18.04M-27.56M-26.83M-28.35M-29.98M-39.06M-42.60M-49.90M-49.10M-26.56M-39.81M-50.80M-51.85M-60.75M-78.95M-59.10M
Additional items
EPS (Basic) -11.85-17.73-13.19-7.80-1.40-0.53-0.25-0.63-0.67-0.52-0.83-0.73-0.74-0.59-0.61-0.93-0.90-0.96-1.01-1.30-1.41-1.26-1.13-0.62-0.77-0.74-0.75-0.88-1.14-0.85
EPS (Weighted Average and Diluted) -0.40-0.63-0.52-0.85-0.73-0.74-0.59-0.61-0.93-0.90-0.96-1.01-1.30-1.41-1.26-1.13-0.62-0.77-0.74-0.75-0.88-1.14-0.85
Shares Outstanding (Weighted Average) 17.70M17.70M17.90M17.90M17.99M17.99M18.09M19.28M21.30M23.09M24.08M25.51M29.40M29.60M29.65M29.68M29.69M30.02M30.04M41.42M42.42M42.59M68.99M68.99M69.05M69.25M69.31M69.31M
Shares Outstanding (Diluted Average) 11.05M18.08M19.43M19.15M22.10M24.05M25.04M25.06M29.61M29.65M29.68M29.66M30.00M30.19M39.58M35.59M42.56M51.99M68.99M58.21M69.20M69.25M69.30M
EBITDA -0.74M-8.23M-7.06M-5.42M-11.73M-9.91M-3.33M-13.51M-12.12M-9.39M-17.65M-16.25M-18.17M-14.37M-18.23M-26.64M-24.73M-27.45M-30.12M-39.38M-43.55M-46.14M-53.29M-26.04M-40.13M-52.90M-48.55M-62.33M-80.85M-59.21M
Interest Expenses 0.52M0.82M0.82M0.82M0.82M0.88M0.82M0.83M0.81M0.82M0.81M0.82M0.82M0.82M0.03M0.05M0.05M0.05M0.04M
Tax Rate 0.063.373.040.940.824.720.312.061.112.753.951.501.640.831.561.205.681.496.361.871.780.29